nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.102	0.664	CbGbCtD
Atomoxetine—CYP3A4—Colchicine—primary biliary cirrhosis	0.0514	0.336	CbGbCtD
Atomoxetine—Gastrointestinal symptom NOS—Colchicine—primary biliary cirrhosis	0.017	0.0253	CcSEcCtD
Atomoxetine—Pharyngolaryngeal pain—Colchicine—primary biliary cirrhosis	0.0148	0.022	CcSEcCtD
Atomoxetine—Laryngeal pain—Colchicine—primary biliary cirrhosis	0.0146	0.0218	CcSEcCtD
Atomoxetine—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00992	0.0148	CcSEcCtD
Atomoxetine—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00992	0.0148	CcSEcCtD
Atomoxetine—Dysmenorrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00985	0.0147	CcSEcCtD
Atomoxetine—Dysmenorrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00985	0.0147	CcSEcCtD
Atomoxetine—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00966	0.0144	CcSEcCtD
Atomoxetine—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00966	0.0144	CcSEcCtD
Atomoxetine—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00751	0.0112	CcSEcCtD
Atomoxetine—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00751	0.0112	CcSEcCtD
Atomoxetine—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.006	0.00895	CcSEcCtD
Atomoxetine—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00594	0.00887	CcSEcCtD
Atomoxetine—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00594	0.00887	CcSEcCtD
Atomoxetine—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00588	0.00877	CcSEcCtD
Atomoxetine—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00588	0.00877	CcSEcCtD
Atomoxetine—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00562	0.00839	CcSEcCtD
Atomoxetine—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00562	0.00839	CcSEcCtD
Atomoxetine—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00539	0.00804	CcSEcCtD
Atomoxetine—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00539	0.00804	CcSEcCtD
Atomoxetine—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00526	0.00785	CcSEcCtD
Atomoxetine—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00526	0.00785	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00522	0.0078	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00522	0.0078	CcSEcCtD
Atomoxetine—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00519	0.00775	CcSEcCtD
Atomoxetine—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00519	0.00775	CcSEcCtD
Atomoxetine—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00508	0.00759	CcSEcCtD
Atomoxetine—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00508	0.00759	CcSEcCtD
Atomoxetine—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00501	0.00748	CcSEcCtD
Atomoxetine—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00501	0.00748	CcSEcCtD
Atomoxetine—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00501	0.00748	CcSEcCtD
Atomoxetine—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00501	0.00748	CcSEcCtD
Atomoxetine—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.005	0.00746	CcSEcCtD
Atomoxetine—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.005	0.00746	CcSEcCtD
Atomoxetine—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00498	0.00744	CcSEcCtD
Atomoxetine—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00487	0.00727	CcSEcCtD
Atomoxetine—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00487	0.00727	CcSEcCtD
Atomoxetine—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0047	0.00702	CcSEcCtD
Atomoxetine—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0047	0.00702	CcSEcCtD
Atomoxetine—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00451	0.00674	CcSEcCtD
Atomoxetine—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00444	0.00663	CcSEcCtD
Atomoxetine—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00444	0.00663	CcSEcCtD
Atomoxetine—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00441	0.00658	CcSEcCtD
Atomoxetine—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00441	0.00658	CcSEcCtD
Atomoxetine—Malnutrition—Colchicine—primary biliary cirrhosis	0.00436	0.00651	CcSEcCtD
Atomoxetine—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00419	0.00626	CcSEcCtD
Atomoxetine—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00418	0.00623	CcSEcCtD
Atomoxetine—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00418	0.00623	CcSEcCtD
Atomoxetine—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00408	0.00609	CcSEcCtD
Atomoxetine—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00408	0.00609	CcSEcCtD
Atomoxetine—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00405	0.00605	CcSEcCtD
Atomoxetine—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00405	0.00605	CcSEcCtD
Atomoxetine—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00404	0.00603	CcSEcCtD
Atomoxetine—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00404	0.00603	CcSEcCtD
Atomoxetine—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00392	0.00585	CcSEcCtD
Atomoxetine—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00392	0.00585	CcSEcCtD
Atomoxetine—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00386	0.00576	CcSEcCtD
Atomoxetine—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00386	0.00576	CcSEcCtD
Atomoxetine—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00384	0.00574	CcSEcCtD
Atomoxetine—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00384	0.00574	CcSEcCtD
Atomoxetine—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0038	0.00568	CcSEcCtD
Atomoxetine—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0038	0.00568	CcSEcCtD
Atomoxetine—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00379	0.00565	CcSEcCtD
Atomoxetine—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00379	0.00565	CcSEcCtD
Atomoxetine—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00562	CcSEcCtD
Atomoxetine—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00562	CcSEcCtD
Atomoxetine—Myalgia—Colchicine—primary biliary cirrhosis	0.00371	0.00554	CcSEcCtD
Atomoxetine—Arthralgia—Colchicine—primary biliary cirrhosis	0.00371	0.00554	CcSEcCtD
Atomoxetine—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00525	CcSEcCtD
Atomoxetine—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00525	CcSEcCtD
Atomoxetine—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00351	0.00524	CcSEcCtD
Atomoxetine—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00351	0.00524	CcSEcCtD
Atomoxetine—Shock—Colchicine—primary biliary cirrhosis	0.0035	0.00522	CcSEcCtD
Atomoxetine—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00349	0.00521	CcSEcCtD
Atomoxetine—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00517	CcSEcCtD
Atomoxetine—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00517	CcSEcCtD
Atomoxetine—Skin disorder—Colchicine—primary biliary cirrhosis	0.00346	0.00516	CcSEcCtD
Atomoxetine—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00344	0.00514	CcSEcCtD
Atomoxetine—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00344	0.00514	CcSEcCtD
Atomoxetine—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00342	0.0051	CcSEcCtD
Atomoxetine—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00342	0.0051	CcSEcCtD
Atomoxetine—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00339	0.00507	CcSEcCtD
Atomoxetine—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00339	0.00507	CcSEcCtD
Atomoxetine—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00333	0.00498	CcSEcCtD
Atomoxetine—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00333	0.00498	CcSEcCtD
Atomoxetine—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00333	0.00498	CcSEcCtD
Atomoxetine—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00333	0.00498	CcSEcCtD
Atomoxetine—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00333	0.00498	CcSEcCtD
Atomoxetine—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00333	0.00498	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00331	0.00494	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00331	0.00494	CcSEcCtD
Atomoxetine—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00487	CcSEcCtD
Atomoxetine—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00487	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00324	0.00484	CcSEcCtD
Atomoxetine—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00474	CcSEcCtD
Atomoxetine—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00474	CcSEcCtD
Atomoxetine—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00469	CcSEcCtD
Atomoxetine—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00469	CcSEcCtD
Atomoxetine—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00313	0.00468	CcSEcCtD
Atomoxetine—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00313	0.00468	CcSEcCtD
Atomoxetine—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00312	0.00466	CcSEcCtD
Atomoxetine—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00312	0.00466	CcSEcCtD
Atomoxetine—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00463	CcSEcCtD
Atomoxetine—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0031	0.00463	CcSEcCtD
Atomoxetine—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00309	0.00462	CcSEcCtD
Atomoxetine—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00309	0.00461	CcSEcCtD
Atomoxetine—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00309	0.00461	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00307	0.00458	CcSEcCtD
Atomoxetine—Fatigue—Colchicine—primary biliary cirrhosis	0.00307	0.00458	CcSEcCtD
Atomoxetine—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00455	CcSEcCtD
Atomoxetine—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00455	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00291	0.00435	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00291	0.00435	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00291	0.00434	CcSEcCtD
Atomoxetine—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00289	0.00432	CcSEcCtD
Atomoxetine—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00289	0.00432	CcSEcCtD
Atomoxetine—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00428	CcSEcCtD
Atomoxetine—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00428	CcSEcCtD
Atomoxetine—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00424	CcSEcCtD
Atomoxetine—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00424	CcSEcCtD
Atomoxetine—Urticaria—Colchicine—primary biliary cirrhosis	0.00283	0.00422	CcSEcCtD
Atomoxetine—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00281	0.0042	CcSEcCtD
Atomoxetine—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00281	0.0042	CcSEcCtD
Atomoxetine—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00281	0.0042	CcSEcCtD
Atomoxetine—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00415	CcSEcCtD
Atomoxetine—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00278	0.00415	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00412	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00412	CcSEcCtD
Atomoxetine—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00411	CcSEcCtD
Atomoxetine—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00411	CcSEcCtD
Atomoxetine—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00273	0.00408	CcSEcCtD
Atomoxetine—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00273	0.00408	CcSEcCtD
Atomoxetine—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00273	0.00408	CcSEcCtD
Atomoxetine—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00273	0.00408	CcSEcCtD
Atomoxetine—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00393	CcSEcCtD
Atomoxetine—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00263	0.00393	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0039	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0039	CcSEcCtD
Atomoxetine—Asthenia—Colchicine—primary biliary cirrhosis	0.00255	0.00381	CcSEcCtD
Atomoxetine—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00379	CcSEcCtD
Atomoxetine—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00379	CcSEcCtD
Atomoxetine—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00377	CcSEcCtD
Atomoxetine—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00377	CcSEcCtD
Atomoxetine—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00377	CcSEcCtD
Atomoxetine—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00377	CcSEcCtD
Atomoxetine—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00243	0.00363	CcSEcCtD
Atomoxetine—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00342	CcSEcCtD
Atomoxetine—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00342	CcSEcCtD
Atomoxetine—Vomiting—Colchicine—primary biliary cirrhosis	0.00226	0.00338	CcSEcCtD
Atomoxetine—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00226	0.00338	CcSEcCtD
Atomoxetine—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00226	0.00338	CcSEcCtD
Atomoxetine—Rash—Colchicine—primary biliary cirrhosis	0.00224	0.00335	CcSEcCtD
Atomoxetine—Dermatitis—Colchicine—primary biliary cirrhosis	0.00224	0.00335	CcSEcCtD
Atomoxetine—Headache—Colchicine—primary biliary cirrhosis	0.00223	0.00333	CcSEcCtD
Atomoxetine—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00326	CcSEcCtD
Atomoxetine—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00326	CcSEcCtD
Atomoxetine—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00316	CcSEcCtD
Atomoxetine—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00316	CcSEcCtD
Atomoxetine—Nausea—Colchicine—primary biliary cirrhosis	0.00211	0.00315	CcSEcCtD
Atomoxetine—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00303	CcSEcCtD
Atomoxetine—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00203	0.00303	CcSEcCtD
Atomoxetine—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00301	CcSEcCtD
Atomoxetine—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00301	CcSEcCtD
Atomoxetine—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00301	CcSEcCtD
Atomoxetine—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00301	CcSEcCtD
Atomoxetine—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.002	0.00299	CcSEcCtD
Atomoxetine—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.002	0.00299	CcSEcCtD
Atomoxetine—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00283	CcSEcCtD
Atomoxetine—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00283	CcSEcCtD
Atomoxetine—Fenoprofen—ALB—primary biliary cirrhosis	0.000775	0.221	CrCbGaD
Atomoxetine—Phenprocoumon—ALB—primary biliary cirrhosis	0.000668	0.19	CrCbGaD
Atomoxetine—Fluoxetine—ALB—primary biliary cirrhosis	0.00065	0.185	CrCbGaD
Atomoxetine—Warfarin—ALB—primary biliary cirrhosis	0.000593	0.169	CrCbGaD
Atomoxetine—Ketoprofen—ALB—primary biliary cirrhosis	0.000458	0.13	CrCbGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000369	0.00212	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000367	0.00211	CbGpPWpGaD
Atomoxetine—Nortriptyline—ALB—primary biliary cirrhosis	0.000365	0.104	CrCbGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000355	0.00204	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000355	0.00204	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000346	0.00199	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000345	0.00199	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000344	0.00198	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000343	0.00197	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000341	0.00196	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.00034	0.00196	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000336	0.00193	CbGpPWpGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000334	0.00192	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000327	0.00188	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000324	0.00187	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000319	0.00184	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000317	0.00183	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000314	0.00181	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000314	0.00181	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000314	0.00181	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000311	0.00179	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000311	0.00179	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000311	0.00179	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000306	0.00176	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000305	0.00175	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000305	0.00175	CbGpPWpGaD
Atomoxetine—HTR2C—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000304	0.00175	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000301	0.00174	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000299	0.00172	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000295	0.0017	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—AGT—primary biliary cirrhosis	0.00029	0.00167	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000289	0.00167	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000289	0.00166	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000287	0.00165	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000285	0.00164	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000283	0.00163	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000281	0.00162	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000279	0.00161	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000277	0.00159	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000276	0.00159	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000273	0.00157	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000272	0.00156	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000271	0.00156	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000266	0.00153	CbGpPWpGaD
Atomoxetine—HTR2A—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000264	0.00152	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—GGT1—primary biliary cirrhosis	0.000262	0.00151	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000256	0.00148	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000254	0.00146	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000249	0.00143	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000247	0.00142	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000246	0.00141	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000243	0.0014	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000242	0.00139	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	0.000241	0.00139	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000241	0.00139	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000238	0.00137	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000236	0.00136	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000231	0.00133	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000231	0.00133	CbGpPWpGaD
Atomoxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000222	0.00128	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000221	0.00127	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000217	0.00125	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000217	0.00125	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000213	0.00123	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00021	0.00121	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000209	0.0012	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000208	0.0012	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000207	0.00119	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000204	0.00118	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000203	0.00117	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000202	0.00116	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000201	0.00116	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000201	0.00115	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000201	0.00115	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000198	0.00114	CbGpPWpGaD
Atomoxetine—SLC6A3—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000197	0.00113	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000192	0.00111	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000191	0.0011	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000187	0.00108	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000185	0.00107	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000185	0.00106	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000184	0.00106	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000183	0.00105	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000182	0.00105	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—LBR—primary biliary cirrhosis	0.000181	0.00104	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.00018	0.00104	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000178	0.00102	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000176	0.00102	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000175	0.00101	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000172	0.000988	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—AGT—primary biliary cirrhosis	0.000171	0.000985	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000168	0.000968	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000167	0.000961	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	0.000166	0.000956	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000163	0.000941	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000163	0.00094	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000162	0.000933	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000159	0.000916	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000159	0.000914	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	0.000158	0.000908	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000156	0.000896	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000154	0.000889	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000153	0.000882	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CD80—primary biliary cirrhosis	0.000152	0.000872	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000151	0.000871	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000148	0.000854	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000147	0.000847	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000144	0.00083	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000142	0.000816	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000141	0.000809	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.00014	0.000803	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000137	0.000787	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000136	0.000785	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000135	0.000779	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000134	0.000773	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000133	0.000766	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000131	0.000757	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	0.000131	0.000752	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TYK2—primary biliary cirrhosis	0.000128	0.000736	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000128	0.000735	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000127	0.000729	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000124	0.000714	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000124	0.000713	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000123	0.000709	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.00012	0.000692	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	0.00012	0.000691	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000118	0.000682	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000118	0.000678	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000118	0.000677	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000117	0.000672	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	0.000116	0.00067	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000115	0.00066	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000114	0.000658	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	0.000113	0.00065	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	0.000109	0.00063	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	0.000109	0.00063	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000109	0.000629	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	0.000109	0.000625	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000108	0.000619	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	0.000107	0.000616	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000107	0.000615	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000106	0.00061	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000104	0.000601	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000104	0.000597	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000104	0.000596	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000101	0.00058	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MMP9—primary biliary cirrhosis	0.000101	0.00058	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	0.000101	0.000579	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	0.000101	0.000579	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	0.0001	0.000576	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NFKB1—primary biliary cirrhosis	9.97e-05	0.000574	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—MMP3—primary biliary cirrhosis	9.96e-05	0.000574	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ELMO1—primary biliary cirrhosis	9.95e-05	0.000573	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL10—primary biliary cirrhosis	9.48e-05	0.000546	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL5—primary biliary cirrhosis	9.4e-05	0.000541	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCL5—primary biliary cirrhosis	8.99e-05	0.000518	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	8.97e-05	0.000516	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL10—primary biliary cirrhosis	8.76e-05	0.000504	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL10—primary biliary cirrhosis	8.69e-05	0.000501	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—AGT—primary biliary cirrhosis	8.66e-05	0.000499	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—MMP3—primary biliary cirrhosis	8.65e-05	0.000498	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL10—primary biliary cirrhosis	8.51e-05	0.00049	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL5—primary biliary cirrhosis	8.16e-05	0.00047	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP3—primary biliary cirrhosis	7.99e-05	0.00046	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.99e-05	0.00046	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP3—primary biliary cirrhosis	7.93e-05	0.000457	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.93e-05	0.000456	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—AGT—primary biliary cirrhosis	7.86e-05	0.000453	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	7.85e-05	0.000452	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP3—primary biliary cirrhosis	7.76e-05	0.000447	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—TYK2—primary biliary cirrhosis	7.76e-05	0.000447	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL5—primary biliary cirrhosis	7.54e-05	0.000434	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—AGT—primary biliary cirrhosis	7.52e-05	0.000433	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL5—primary biliary cirrhosis	7.48e-05	0.000431	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL5—primary biliary cirrhosis	7.33e-05	0.000422	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.31e-05	0.000421	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.25e-05	0.000418	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.1e-05	0.000409	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	7e-05	0.000403	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	6.98e-05	0.000402	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—AGT—primary biliary cirrhosis	6.83e-05	0.000393	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	6.58e-05	0.000379	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	6.58e-05	0.000379	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	6.58e-05	0.000379	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.45e-05	0.000371	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.33e-05	0.000365	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—AGT—primary biliary cirrhosis	6.31e-05	0.000363	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.28e-05	0.000362	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—AGT—primary biliary cirrhosis	6.26e-05	0.00036	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.15e-05	0.000354	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—AGT—primary biliary cirrhosis	6.13e-05	0.000353	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	6.11e-05	0.000352	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	6.05e-05	0.000348	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP3—primary biliary cirrhosis	5.88e-05	0.000339	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—TYK2—primary biliary cirrhosis	5.88e-05	0.000339	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	5.62e-05	0.000324	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.6e-05	0.000323	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CD80—primary biliary cirrhosis	5.59e-05	0.000322	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL5—primary biliary cirrhosis	5.55e-05	0.00032	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CD80—primary biliary cirrhosis	5.55e-05	0.000319	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CD80—primary biliary cirrhosis	5.43e-05	0.000313	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.38e-05	0.00031	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.36e-05	0.000309	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	5.24e-05	0.000302	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	5.2e-05	0.000299	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP3—primary biliary cirrhosis	5.11e-05	0.000294	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—TYK2—primary biliary cirrhosis	5.11e-05	0.000294	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	4.82e-05	0.000278	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL5—primary biliary cirrhosis	4.82e-05	0.000278	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	4.78e-05	0.000275	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TYK2—primary biliary cirrhosis	4.72e-05	0.000272	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TYK2—primary biliary cirrhosis	4.68e-05	0.00027	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.67e-05	0.000269	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.66e-05	0.000268	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—AGT—primary biliary cirrhosis	4.65e-05	0.000267	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TYK2—primary biliary cirrhosis	4.58e-05	0.000264	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	4.49e-05	0.000258	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	4.49e-05	0.000258	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	4.13e-05	0.000238	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	4.13e-05	0.000238	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CD80—primary biliary cirrhosis	4.12e-05	0.000237	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.05e-05	0.000233	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AGT—primary biliary cirrhosis	4.03e-05	0.000232	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	3.99e-05	0.00023	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	3.95e-05	0.000228	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP9—primary biliary cirrhosis	3.72e-05	0.000214	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP9—primary biliary cirrhosis	3.69e-05	0.000212	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.68e-05	0.000212	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	3.68e-05	0.000212	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	3.67e-05	0.000211	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.65e-05	0.00021	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP9—primary biliary cirrhosis	3.61e-05	0.000208	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CD80—primary biliary cirrhosis	3.57e-05	0.000206	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.57e-05	0.000206	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TYK2—primary biliary cirrhosis	3.47e-05	0.0002	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	3.15e-05	0.000182	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	3.13e-05	0.00018	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	3.11e-05	0.000179	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TYK2—primary biliary cirrhosis	3.02e-05	0.000174	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	2.86e-05	0.000165	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP9—primary biliary cirrhosis	2.74e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.71e-05	0.000156	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.7e-05	0.000155	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.7e-05	0.000155	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.4e-05	0.000138	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	2.39e-05	0.000137	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP9—primary biliary cirrhosis	2.38e-05	0.000137	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.35e-05	0.000135	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	2.19e-05	0.000126	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.87e-05	0.000108	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.44e-05	8.26e-05	CbGpPWpGaD
